title: CDK4/6 inhibition: the late harvest cycle begins.
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Shom
authors.initials: S
authors.lastname: Goel
authors.affiliation: Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.|Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.|The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
authors.forename: Jean J
authors.initials: JJ
authors.lastname: Zhao
mesh_terms: D000818:Animals; D002453:Cell Cycle / Q000187:drug effects*; D051358:Cyclin-Dependent Kinase 4 / Q000037:antagonists & inhibitors*; D051361:Cyclin-Dependent Kinase 6 / Q000037:antagonists & inhibitors*; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology*
chemical_list: C495900:CDK4 protein, human; C495911:CDK6 protein, human; D051358:Cyclin-Dependent Kinase 4; D051361:Cyclin-Dependent Kinase 6
keywords: CDK4/6; abemaciclib; cancer; cell cycle; cyclin